Vaginal Applicator Development for Delivery of Microarray Patches Containing Rilpivirine for HIV Pre-exposure Prophylaxis

As part of PATH’s work in vaccine and pharmaceutical delivery technologies, this poster highlights PATH’s four-phase approach to designing a dissolvable microarray patch (MAP) for vaginal delivery of rilpivirine. In addition, the poster discusses the ways by which the approach has helped to define design requirements for an effective and discreet method (i.e., applicator) for delivering the long-lasting rilpivirine MAP for HIV pre-exposure prophylaxis.

Publication date: May 2016

Vaginal Applicator Development for Delivery of Microarray Patches Containing Rilpivirine for HIV Pre-exposure Prophylaxis

1.2 MB PDF

Hard copies are not available.

View Resource